[
  {
    "ts": null,
    "headline": "Charles River Laboratories: Not The Right Time To Own At This Point In The Cycle",
    "summary": "Charles River Laboratories presents with optimistic growth expectations that seem a stretch given the business's current performance. See why CRL stock is a Hold.",
    "url": "https://finnhub.io/api/news?id=69c7e6f103d1bab486003440a6f8fd203d09813879531dbfb56d6cd3f7a6a980",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731997184,
      "headline": "Charles River Laboratories: Not The Right Time To Own At This Point In The Cycle",
      "id": 131468215,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1220627489/image_1220627489.jpg?io=getty-c-w1536",
      "related": "CRL",
      "source": "SeekingAlpha",
      "summary": "Charles River Laboratories presents with optimistic growth expectations that seem a stretch given the business's current performance. See why CRL stock is a Hold.",
      "url": "https://finnhub.io/api/news?id=69c7e6f103d1bab486003440a6f8fd203d09813879531dbfb56d6cd3f7a6a980"
    }
  }
]